GUIZHOU SANLI PHARMACEUTICAL CO.,LTD. — Investor Relations & Filings
About GUIZHOU SANLI PHARMACEUTICAL CO.,LTD.
Guizhou Sanli Pharmaceutical Co., Ltd. specializes in the research, development, production, and distribution of traditional Chinese medicine (TCM) preparations. The company focuses on respiratory and throat health, with its flagship product line being the Kaihoujian Spray series, available in both pediatric and adult formulations. These products are primarily used for treating inflammatory conditions of the throat and oral cavity. The company maintains a strong market position in the pediatric TCM segment through its specialized spray delivery systems and proprietary formulations. Its operations encompass the entire value chain from pharmaceutical manufacturing to marketing and sales, emphasizing the modernization of traditional herbal remedies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 贵州三力制药股份有限公司关于变更注册资本和经营范围并修订《公司章程》的公告 | 2026-04-26 | Chinese | |
| 贵州三力制药股份有限公司独立董事2025年度述职报告（归东） | 2026-04-26 | Chinese | |
| 贵州三力制药股份有限公司关于召开2025年年度股东会的通知 | 2026-04-26 | Chinese | |
| 2025年度非经营性资金占用及其他关联资金往来情况 | 2026-04-26 | Chinese | |
| 董事会关于公司独立董事2025年度独立性情况的专项意见 | 2026-04-26 | Chinese | |
| 贵州三力制药股份有限公司内部控制审计报告 | 2026-04-26 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39786204 | 贵州三力制药股份有限公司关于变更注册资本和经营范围并修订《公司章程》的公告 | 2026-04-26 | Chinese | ||
| 39786203 | 贵州三力制药股份有限公司独立董事2025年度述职报告（归东） | 2026-04-26 | Chinese | ||
| 39786200 | 贵州三力制药股份有限公司关于召开2025年年度股东会的通知 | 2026-04-26 | Chinese | ||
| 39786199 | 2025年度非经营性资金占用及其他关联资金往来情况 | 2026-04-26 | Chinese | ||
| 39786195 | 董事会关于公司独立董事2025年度独立性情况的专项意见 | 2026-04-26 | Chinese | ||
| 39786193 | 贵州三力制药股份有限公司内部控制审计报告 | 2026-04-26 | Chinese | ||
| 39786189 | 北京市中伦律师事务所关于贵州三力制药股份有限公司限制性股票激励计划之回购注销部分限制性股票事项的法律意见书 | 2026-04-26 | Chinese | ||
| 39786187 | 贵州三力制药股份有限公司独立董事2025年度述职报告（陈世贵） | 2026-04-26 | Chinese | ||
| 39786184 | 2025年度董事会工作报告 | 2026-04-26 | Chinese | ||
| 39786171 | 贵州三力制药股份有限公司关于计提资产减值准备的公告 | 2026-04-26 | Chinese | ||
| 39786168 | 2025年度总经理工作报告 | 2026-04-26 | Chinese | ||
| 39786166 | 贵州三力制药股份有限公司关于2024年限制性股票激励计划第一个解除限售期解除限售条件未成就暨回购注销部分限制性股票的公告 | 2026-04-26 | Chinese | ||
| 39786162 | 贵州三力制药股份有限公司关于续聘会计师事务所的公告 | 2026-04-26 | Chinese | ||
| 39786159 | 贵州三力制药股份有限公司关于回购注销部分限制性股票减资暨通知债权人的公告 | 2026-04-26 | Chinese | ||
| 39786157 | 贵州三力制药股份有限公司关于2026年度使用部分自有资金进行现金管理的公告 | 2026-04-26 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
GUIZHOU SANLI PHARMACEUTICAL CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57668/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57668 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57668 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57668 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57668}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GUIZHOU SANLI PHARMACEUTICAL CO.,LTD. (id: 57668)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.